AGT and cardiac hypertrophy: We found that tRF-Glu-CTC-013 significantly reduced the Ang II-induced increase in cardiomyocyte surface area, as well as reducing the expression of the cardiac hypertrophy markers Nppa, Nppb and Myh7 (Fig. 4A-E).